BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 26040981)

  • 21. AFF4 promotes tumorigenesis and tumor-initiation capacity of head and neck squamous cell carcinoma cells by regulating SOX2.
    Deng P; Wang J; Zhang X; Wu X; Ji N; Li J; Zhou M; Jiang L; Zeng X; Chen Q
    Carcinogenesis; 2018 Jul; 39(7):937-947. PubMed ID: 29741610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
    Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
    Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SOX2 activation predicts prognosis in patients with head and neck squamous cell carcinoma.
    Chung JH; Jung HR; Jung AR; Lee YC; Kong M; Lee JS; Eun YG
    Sci Rep; 2018 Jan; 8(1):1677. PubMed ID: 29374236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of Genes Encoding Cell Motility Proteins during Progression of Head and Neck Squamous Cell Carcinoma.
    Kakurina GV; Kondakova IV; Spirina LV; Kolegova ES; Shashova EE; Cheremisina OV; Novikov VA; Choinzonov EL
    Bull Exp Biol Med; 2018 Dec; 166(2):250-252. PubMed ID: 30488206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
    Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
    BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sox11 promotes head and neck cancer progression via the regulation of SDCCAG8.
    Huang J; Ji EH; Zhao X; Cui L; Misuno K; Guo M; Huang Z; Chen X; Hu S
    J Exp Clin Cancer Res; 2019 Mar; 38(1):138. PubMed ID: 30922366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KLF4, Slug and EMT in Head and Neck Squamous Cell Carcinoma.
    Ingruber J; Savic D; Steinbichler TB; Sprung S; Fleischer F; Glueckert R; Schweigl G; Skvortsova II; Riechelmann H; Dudás J
    Cells; 2021 Mar; 10(3):. PubMed ID: 33802627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of lncRNA WWTR1-AS1 associates with tumor aggressiveness and unfavorable survival in head-neck squamous cell carcinoma.
    Li J; Li Z; Wu Y; Diao P; Zhang W; Wang Y; Yang J; Cheng J
    J Cell Biochem; 2019 Oct; 120(10):18266-18277. PubMed ID: 31172583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of submaxillary gland androgen-regulated protein 3A via estrogen receptor 2 in radioresistant head and neck squamous cell carcinoma cells.
    Grünow J; Rong C; Hischmann J; Zaoui K; Flechtenmacher C; Weber KJ; Plinkert P; Hess J
    J Exp Clin Cancer Res; 2017 Feb; 36(1):25. PubMed ID: 28166815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma.
    Kinoshita T; Nohata N; Hanazawa T; Kikkawa N; Yamamoto N; Yoshino H; Itesako T; Enokida H; Nakagawa M; Okamoto Y; Seki N
    Br J Cancer; 2013 Nov; 109(10):2636-45. PubMed ID: 24091622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevance.
    Hess J; Unger K; Orth M; Schötz U; Schüttrumpf L; Zangen V; Gimenez-Aznar I; Michna A; Schneider L; Stamp R; Selmansberger M; Braselmann H; Hieber L; Drexler GA; Kuger S; Klein D; Jendrossek V; Friedl AA; Belka C; Zitzelsberger H; Lauber K
    Cancer Lett; 2017 Feb; 386():87-99. PubMed ID: 27867017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-375 Regulates Invasion-Related Proteins Vimentin and L-Plastin.
    Jimenez L; Lim J; Burd B; Harris TM; Ow TJ; Kawachi N; Belbin TJ; Angeletti R; Prystowsky MB; Childs G; Segall JE
    Am J Pathol; 2017 Jul; 187(7):1523-1536. PubMed ID: 28499703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness.
    Jing C; Duan Y; Zhou M; Yue K; Zhuo S; Li X; Liu D; Ye B; Lai Q; Li L; Yao X; Wei H; Zhang W; Wu Y; Wang X
    Theranostics; 2021; 11(6):2655-2669. PubMed ID: 33456565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma.
    Liu C; Guo T; Sakai A; Ren S; Fukusumi T; Ando M; Sadat S; Saito Y; Califano JA
    Cancer; 2020 Feb; 126(4):737-748. PubMed ID: 31721164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.
    Sepiashvili L; Hui A; Ignatchenko V; Shi W; Su S; Xu W; Huang SH; O'Sullivan B; Waldron J; Irish JC; Perez-Ordonez B; Liu FF; Kislinger T
    Mol Cell Proteomics; 2012 Nov; 11(11):1404-15. PubMed ID: 22918226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD44 variant isoforms in head and neck squamous cell carcinoma progression.
    Wang SJ; Wong G; de Heer AM; Xia W; Bourguignon LY
    Laryngoscope; 2009 Aug; 119(8):1518-30. PubMed ID: 19507218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MELK inhibition targets cancer stem cells through downregulation of SOX2 expression in head and neck cancer cells.
    Ren L; Deng B; Saloura V; Park JH; Nakamura Y
    Oncol Rep; 2019 Apr; 41(4):2540-2548. PubMed ID: 30720113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TRIM24 overexpression is common in locally advanced head and neck squamous cell carcinoma and correlates with aggressive malignant phenotypes.
    Cui Z; Cao W; Li J; Song X; Mao L; Chen W
    PLoS One; 2013; 8(5):e63887. PubMed ID: 23717505
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; Franzen A; Dietrich J; Kristiansen G; Bootz F; Schröck A; Dietrich D
    Clin Epigenetics; 2017; 9():12. PubMed ID: 28174607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-193b enhances tumor progression via down regulation of neurofibromin 1.
    Lenarduzzi M; Hui AB; Alajez NM; Shi W; Williams J; Yue S; O'Sullivan B; Liu FF
    PLoS One; 2013; 8(1):e53765. PubMed ID: 23335975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.